Purification of phage display-modified bacteriophage T4 by affinity chromatography

BMC Biotechnology

Volumn 11, Issue , 2011, Pages

  Oślizło, Anna ^a   Miernikiewicz, Paulina ^a   Piotrowicz, Agnieszka ^a   Owczarek, Barbara ^a   Kopciuch, Agnieszka ^a   Figura, Grzegorz ^a   Dabrowska, Krystyna ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY RESINS; AFFINITY TAGS; BACTERIAL PLASMID; BACTERIOPHAGE T4; DISPLAY PLATFORM; ELUTION PROFILES; EXPRESSION VECTORS; GLUTATHIONES; HIS-TAG; IN-VIVO; NON-SPECIFIC BINDING; PHAGE DISPLAY; PROTEIN PURIFICATION; PROTEOLYTIC CLEAVAGE; PURIFICATION METHOD; SPECIFIC RESIN;

AFFINITY CHROMATOGRAPHY; BACTERIOLOGY; BACTERIOPHAGES; GEL PERMEATION CHROMATOGRAPHY; GENES; PROTEINS; RESINS; WASHING;

PURIFICATION;

RESIN; CAPSID PROTEIN; GLUTATHIONE; HIS HIS HIS HIS HIS HIS; HIS-HIS-HIS-HIS-HIS-HIS; HISTIDINE; HOC PROTEIN, T4 PHAGE; HYBRID PROTEIN; OLIGOPEPTIDE; PEPTIDE LIBRARY;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIOPHAGE; DNA EXTRACTION; ELUTION; EXPRESSION VECTOR; GENOME; NONHUMAN; PHAGE DISPLAY; PLASMID; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PURIFICATION; BACTERIOPHAGE T4; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR CLONING;

BACTERIA (MICROORGANISMS); MIRIDAE;

BACTERIOPHAGE T4; CAPSID PROTEINS; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; GLUTATHIONE; HISTIDINE; OLIGOPEPTIDES; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS;

EID: 79957646194     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-11-59     Document Type: Article

References (28)

1. McLaughlin MR, King RA. Characterization of Salmonella bacteriophages isolated from swine lagoon effluent. Curr Microbiol 2008, 56:208-213. 10.1007/s00284-007-9057-9, 17994263.
2. Chibani Azaïez SR, Fliss I, Simard RE, Moineau S. Monoclonal antibodies raised against native major capsid proteins of lactococcal c2-like bacteriophages. Appl Environ Microbiol 1998, 64:4255-4259. 106635, 9797273.
3. Shelton CB, Crosslin DR, Casey JL, Ng S, Temple LM, Orndorff PE. Discovery, purification, and characterization of a temperate transducing bacteriophage for Bordetella avium. J Bacteriol 2000, 182:6130-6136. 10.1128/JB.182.21.6130-6136.2000, 94748, 11029434.
4. Smith GP, Gingrich TR. Hydroxyapatite chromatography of phage-display virions. Biotechniques 2005, 39:879-884. 10.2144/000112032, 16382907.
5. Boratyński J, Syper D, Weber-Dabrowska B, Łusiak-Szelachowska M, Poźniak G, Górski A. Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 2004, 9:253-259.
6. Monjezi R, Tey BT, Sieo CC, Tan WS. Purification of bacteriophage M13 by anion exchange chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:1855-1859. 10.1016/j.jchromb.2010.05.028, 20538529.
7. Ackermann HW. Phage classification and characterization. Methods Mol Biol 2009, 501:127-140. 10.1007/978-1-60327-164-6_13, 19066817.
8. Urh M, Simpson D, Zhao K. Affinity chromatography: general methods. Methods Enzymol 2009, 463:417-438.
9. Smith GP, Petrenko VA. Phage display. Chem Rev 1997, 97:319-410.
10. Maruyama IN, Maruyama HI, Brenner S. Lambda foo: a lambda phage vector for the expression of foreign proteins. PNAS USA 1994, 91:8273-8277. 10.1073/pnas.91.17.8273, 44588, 8058794.
11. Castillo J, Goodson B, Winter J. T7 displayed peptides as targets for selecting peptide specific scFvs from scFvs display libraries. J Immunol Methods 2001, 257:117-122. 10.1016/S0022-1759(01)00454-9, 11687245.
12. Dai M, Temirov J, Pesavento E, Kiss C, Velappan N, Pavlik P, Werner JH, Bradbury AR. Using T7 phage display to select GFP-based binders. Protein Eng Des Sel 2008, 21:413-424. 10.1093/protein/gzn016, 18469345.
13. Lorch A. Bacteriophages: An alternative to antibiotics?. Biotechnology and Development Monitor 1999, 39:14-17.
14. Ackermann HW, Krisch HM. A catalogue of T4-type bacteriophages. Arch Virol 1997, 142:2329-2345. 10.1007/s007050050246, 9672598.
15. Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Rüger W. Bacteriophage T4 genome. Microbiol Mol Biol Rev 2003, 67:86-156. 10.1128/MMBR.67.1.86-156.2003, 150520, 12626685.
16. Ren Z, Black LW. Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid. Gene 1998, 215:439-444. 10.1016/S0378-1119(98)00298-4, 9714843.
17. Ren ZJ, Lewis GK, Wingfield PT, Locke EG, Steven AC, Black LW. Phage display of intact domains at high copy number: A system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Science 1996, 5:1833-1843. 10.1002/pro.5560050909, 2143533, 8880907.
18. Jiang J, Abu-Shilbayeh L, Rao VB. Display of a PorA peptide from Neisseria meningitidis on the bacteriophage T4 capsid surface. Infect Immun 1997, 65:4770-4777. 175684, 9353063.
19. Sathaliyawala T, Rao M, Maclean DM, Birx DL, Alving CR, Rao VB. Assembly of HIV antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. J Virol 2006, 80:7688-7698. 10.1128/JVI.00235-06, 1563720, 16840347.
20. Shivachandra SB, Rao M, Janosi L, Sathaliyawala T, Matyas GR, Alving CR, Leppla SH, Rao VB. In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full length proteins. Virology 2006, 345:190-198. 10.1016/j.virol.2005.10.037, 16316672.
21. Shivachandra SB, Li Q, Peachman KK, Matyas GR, Leppla SH, Alving CR, Rao M, Rao VB. Multicomponent Anthrax toxin display and delivery using bacteriophage T4. Vaccine 2007, 25:1225-1235. 10.1016/j.vaccine.2006.10.010, 1888565, 17069938.
22. Dabrowska K, Zembala M, Boratynski J, Kujawa M, Świtala-Jelen K, Wietrzyk J, Opolski A, Szczaurska K, Godlewska J, Gorski A. Hoc protein regulates the biological effects of T4 phage in mammals. Arch Microbiol 2007, 187:489-498. 10.1007/s00203-007-0216-y, 17294171.
23. Stone R. Stalin's Forgotten Cure. Science 2002, 298:728-731. 10.1126/science.298.5594.728, 12399562.
24. Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2003, 2:489-497. 10.1038/nrd1111, 12776223.
25. Skurnik M, Strauch E. Phage therapy: facts and fiction. Int J Med Microbiol 2006, 296:5-14.
26. Sulakvelidze A. Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. Drug Discov Today 2005, 10:807-809. 10.1016/S1359-6446(05)03441-0, 15970258.
27. Pizzorno J, Murray M. Phage Therapy: Bacteriophages as Nautural Self -Limiting Antibiotics 2005, Churchill/Livingstone.
28. Adams MH. Bacteriophages 2005, New York, Inter. Science Publ.